Development and Reproduction (한국발생생물학회지:발생과생식)

The Korean Society of Developmental Biology (한국발생생물학회)
권호 표지
DOI QR코드

DOI QR Code

Transforming Stimulated Clone 22 (TSC-22) Interacts Directly with Bromodomain-Containing Protein 7 (BRD7) to Enhance the Inhibition of Extracellular Signal-Regulate Kinase (ERK) Pathway in Ovarian Cancer

  • Received : 2022.06.03
  • Accepted : 2022.09.02
  • Published : 2022.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Bromodomain-containing protein 7 (BRD7) participates in many cellular processes and embryo development. BRD7 is down-regulated in various cancers and evidence of its tumor suppressor function has been accumulating. Here, we identified transforming stimulated clone 22 (TSC-22) as a novel BRD7 interacting protein and show its novel function as a positive regulator of BRD7. We found that TSC-22 expression potentiated the inactivation of the extracellular signal-regulate kinase (ERK) pathway by BRD7. Our data establishes TSC-22 as a modulator of BRD7 and unravels the molecular mechanisms that drive the synergistic tumor-suppressing effects of TSC-22 and BRD7. Our findings may open new avenues for developing novel molecular therapies for tumors exhibiting down-regulated BRD7 and/or TSC-22.

Keywords

Acknowledgement

This work was supported by YongIn University research fund (2020).

References

  1. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13:11-26. https://doi.org/10.1038/nrc3419
  2. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899-905.
  3. Chen CL, Wang Y, Pan QZ, Tang Y, Wang QJ, Pan K, Huang LX, He J, Zhao JJ, Jiang SS, Zhang XF, Zhang HX, Zhou ZQ, Weng DS, Xia JC (2016) Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma. Oncotarget 7:16248-16261. https://doi.org/10.18632/oncotarget.7637
  4. Cho MJ, Lee JY, Shin MG, Kim HJ, Choi YJ, Rho SB, Kim BR, Jang IS, Lee SH (2017) TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. Oncotarget 8:97990-98003. https://doi.org/10.18632/oncotarget.20296
  5. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R, Del Sal G (2010) BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol 12:380-389. https://doi.org/10.1038/ncb2038
  6. Gao Y, Wang B, Gao S (2016) BRD7 acts as a tumor suppressor gene in lung adenocarcinoma. PLOS ONE 11:e0156701. https://doi.org/10.1371/journal.pone.0156701
  7. Harte MT, O'Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, Mullan PB, Harkin DP (2010) BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res 70:2538-2547.
  8. Hino S, Kawamata H, Uchida D, Omotehara F, Miwa Y, Begum NM, Yoshida H, Fujimori T, Sato M (2000) Nuclear translocation of TSC-22 (TGF-β-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator. Biochem Biophys Res Commun 278:659-664. https://doi.org/10.1006/bbrc.2000.3840
  9. Kester HA, Blanchetot C, den Hertog J, van der Saag PT, van der Burg B (1999) Transforming growth factor-β-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J Biol Chem 274:27439-27447. https://doi.org/10.1074/jbc.274.39.27439
  10. Kikuchi M, Okumura F, Tsukiyama T, Watanabe M, Miyajima N, Tanaka J, Imamura M, Hatakeyama S (2009) TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochim Biophys Acta 1793:1828-1836. https://doi.org/10.1016/j.bbamcr.2009.11.001
  11. Lee JH, Rho SB, Park SY, Chun T (2008) Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC22. FEBS Lett 582:1210-1218. https://doi.org/10.1016/j.febslet.2008.01.066
  12. Liu T, Zhao M, Liu J, He Z, Zhang Y, You H, Huang J, Lin X, Feng XH (2017) Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses. Oncogene 36:362-372. https://doi.org/10.1038/onc.2016.204
  13. Mantovani F, Drost J, Mathijs Voorhoeve P, Del Sal G, Agami R (2010) Gene regulation and tumor suppression by the bromodomain-containing protein BRD7. Cell Cycle 9:2777-2781.
  14. Meek DW (2015) Regulation of the p53 response and its relationship to cancer. Biochem J 469:325-346. https://doi.org/10.1042/BJ20150517
  15. Nakamura M, Kitaura J, Enomoto Y, Lu Y, Nishimura K, Isobe M, Ozaki K, Komeno Y, Nakahara F, Oki T, Kume H, Homma Y, Kitamura T (2012) Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras/Raf signaling: Implications for tumorigenesis. Cancer Sci 103:26-33. https://doi.org/10.1111/j.1349-7006.2011.02108.x
  16. Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M (1998) Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res 58:549-555.
  17. Park SW, Lee JM (2020) Emerging roles of BRD7 in pathophysiology. Int J Mol Sci 21:7127. https://doi.org/10.3390/ijms21197127
  18. Park YA, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi CH, Kim TJ, Lee NW, Kim BG, Bae DS (2012) The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. Gynecol Oncol 124:125-133. https://doi.org/10.1016/j.ygyno.2011.09.026
  19. Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS (2014) Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clin Cancer Res 20:565-575. https://doi.org/10.1158/1078-0432.CCR-13-1271
  20. Rentsch CA, Cecchini MG, Schwaninger R, Germann M, Markwalder R, Heller M, van der Pluijm G, Thalmann GN, Wetterwald A (2006) Differential expression of TGFβ-stimulated clone 22 in normal prostate and prostate cancer. Int J Cancer 118:899-906. https://doi.org/10.1002/ijc.21449
  21. Shang S, Hua F, Hu ZW (2017) The regulation of β-catenin activity and function in cancer: Therapeutic opportunities. Oncotarget 8:33972-33989. https://doi.org/10.18632/oncotarget.15687
  22. Shibanuma M, Kuroki T, Nose K (1992) Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor β1 and other growth factors. J Biol Chem 267:10219-10224. https://doi.org/10.1016/S0021-9258(19)50006-0
  23. Shostak KO, Dmitrenko VV, Vudmaska MI, Naidenov VG, Beletskii AV, Malisheva TA, Semenova VM, Zozulya YP, Demotes-Mainard J, Kavsan VM (2005) Patterns of expression of TSC-22 protein in astrocytic gliomas. Exp Oncol 27:314-318.
  24. Taketo MM (2004) Shutting down Wnt signal-activated cancer. Nat Genet 36:320-322. Wu M, Li X, Li X, Li G (2009) Signaling transduction network mediated by tumor suppressor/ susceptibility genes in NPC. Curr Genomics 10:216-222.
  25. Wu WJ, Hu KS, Chen DL, Zeng ZL, Luo HY, Wang F, Wang DS, Wang ZQ, He F, Xu RH (2013) Prognostic relevance of BRD7 expression in colorectal carcinoma. Eur J Clin Invest 43:131-140. https://doi.org/10.1111/eci.12024
  26. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, Hung MC (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10:138-148. https://doi.org/10.1038/ncb1676
  27. Yoon CH, Rho SB, Kim ST, Kho S, Park J, Jang IS, Woo S, Kim SS, Lee JH, Lee SH (2012) Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer. PLOS ONE 7:e42006. https://doi.org/10.1371/journal.pone.0042006
  28. Yu X, Li Z, Shen J (2016) BRD7: A novel tumor suppressor gene in different cancers. Am J Transl Res 8:742-748.
  29. Zhou M, Liu H, Xu X, Zhou H, Li X, Peng C, Shen S, Xiong W, Ma J, Zeng Z, Fang S, Nie X, Yang Y, Zhou J, Xiang J, Cao L, Peng S, Li S, Li G (2006) Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem 98:920-930. https://doi.org/10.1002/jcb.20788